Financial Advocates Investment Management Mustang Bio, Inc. Transaction History

Financial Advocates Investment Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.32 - $8.27 $110 - $2,853	-345 Reduced 1.7%	20,000 $7,000
Q3 2022 Nov 14, 2022	SELL	$0.46 - $7.2 $7,684 - $120,276	-16,705 Reduced 45.09%	20,345 $11,000
Q2 2022 Aug 12, 2022	BUY	$0.58 - $1.13 $11,600 - $22,599	20,000 Added 117.3%	37,050 $21,000
Q1 2022 May 11, 2022	BUY	$0.73 - $1.81 $12,446 - $30,860	17,050 New	17,050 $17,000
Q4 2021 Feb 14, 2022	SELL	$1.66 - $2.64 $64,615 - $102,762	-38,925 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$2.58 - $3.36 $30,250 - $39,396	11,725 Added 43.11%	38,925 $105,000
Q2 2021 Aug 03, 2021	SELL	$2.7 - $3.81 $24,772 - $34,956	-9,175 Reduced 25.22%	27,200 $99,000
Q1 2021 May 10, 2021	BUY	$3.02 - $5.16 $44,922 - $76,755	14,875 Added 69.19%	36,375 $121,000
Q4 2020 Feb 12, 2021	BUY	$2.66 - $4.18 $54,530 - $85,690	20,500 Added 2050.0%	21,500 $81,000
Q3 2018 Nov 14, 2018	BUY	$5.71 - $7.58 $5,710 - $7,580	1,000 New	1,000 $0

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $27.4M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

Stay updated on Financial Advocates Investment Management with notifications on news.